INDP is trading at $3.97, up 5.1%, rebounding from the previous session’s close of $3.77.

  • The gain appears to be a technical bounce in the volatile micro-cap biotech rather than a reaction to new fundamental news.
  • There are no fresh company-specific headlines, SEC filings, or analyst calls reported on June 23, 2026, tied to the move.